Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
381.30
0.00 (0.00%)
At close: Sep 19, 2025
Market Cap8.35B
Revenue (ttm)438.99M
Net Income (ttm)-240.04M
Shares Outn/a
EPS (ttm)-10.91
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume7
Open381.30
Previous Close381.30
Day's Range381.30 - 381.30
52-Week Range237.50 - 381.90
Betan/a
RSI65.60
Earnings DateOct 28, 2025

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.